Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

SYRE

Spyre Therapeutics Inc

Jun 08 • 04:00PM ET

72.00

-1.65 -2.24 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: BMRN RYTM APGE KRYS KYMR NUVL AXSM MDGL VKTX NBIX

| Held by: VTI IWM XBI VXF IBB IWO VTWO SCHA IWN VHT

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-2.36	Insider Own	11.01%	Shs Outstand	78.84M	Perf Week	2.07%
Market Cap	6.25B	Forward P/E	-	EPS next Y	-3.19	Insider Trans	-2.99%	Shs Float	77.28M	Perf Month	-1.50%
Enterprise Value	5.67B	PEG	-	EPS next Q	-0.73	Inst Own	87.15%	Short Float	16.07%	Perf Quarter	75.31%
Income	-168.74M	P/S	-	EPS this Y	-48.14%	Inst Trans	1.14%	Short Ratio	11.07	Perf Half Y	114.86%
Sales	0.00M	P/B	11.02	EPS next Y	-8.60%	ROA	-25.30%	Short Interest	12.42M	Perf YTD	119.78%
Book/sh	6.53	P/C	8.43	EPS next 5Y	-22.13%	ROE	-29.26%	52W High	79.54 -9.48%	Perf Year	324.28%
Cash/sh	8.54	P/FCF	-	EPS past 3/5Y	57.01% 44.61%	ROIC	-25.15%	52W Low	13.93 416.87%	Perf 3Y	2125.66%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	7.15% 5.95%	Perf 5Y	-57.65%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	22.31%	Oper. Margin	-	ATR (14)	4.43	Perf 10Y	-60.33%
Dividend Ex-Date	-	Quick Ratio	8.97	Sales Y/Y TTM	-100.00%	Profit Margin	-	RSI (14)	51.01	Recom	1.06
Dividend Gr. 3/5Y	- -	Current Ratio	8.97	EPS Q/Q	-46.71%	SMA20	-1.67%	Beta	3.04	Target Price	96.07
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	6.75%	Rel Volume	0.92	Prev Close	73.65
Employees	102	LT Debt/Eq	0.00	Earnings	May 05 BMO	SMA200	88.08%	Avg Volume	1.12M	Price	72.00
IPO	Apr 07, 2016	Option/Short	Yes / Yes	EPS/Sales Surpr.	-11.18% -	Trades		Volume	1,035,946	Change	-2.24%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)